Raltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority study
2013 ◽
Vol 207
(suppl_2)
◽
pp. S49-S56
◽
2014 ◽
Vol 13
(4)
◽
pp. 366-371
◽
2013 ◽
Vol 107
(10)
◽
pp. 608-614
◽